Skip to main content
Medical information Clinical review pending

Genetic Testing

Toxoplasma Gondii RNA Detection Qualitative Test

Detects the presence of Toxoplasma gondii RNA to identify an active parasitic infection, particularly important for individuals with weakened immune systems or specific symptoms. Uses Real-Time PCR technology.

General information only: This page is not a diagnosis or personal medical advice. A qualified clinician should decide whether testing is appropriate and interpret results in context.

Review status: No completed medical review is recorded for this page.

Ask a question
Counselor guidance included Confidential handling Kenya-wide coordination

At a glance

Plan your test

Sample
Whole blood, urine, serum, tissue, or aqueous humor. Confirm specific sample type required with the laboratory before booking.
Results
Confirm with the laboratory before booking.
Preparation
Generally, no special preparation is required for this test. However, confirm any specific instructions with the laboratory or your doctor.
Test priceKSh 9,520

Payment: M-Pesa and card options can be confirmed during booking.

Insurance & government schemes

Is this test covered for you?

We help you verify whether the Toxoplasma Gondii RNA Detection Qualitative Test test can be claimed against your insurer, employer scheme or a Kenyan government health scheme — before you book. Coverage depends on your plan, clinical indication and your provider's rules; final approval always rests with them.

Talk to a claims advisor

Providers & schemes we can help you check

Government & public schemes

SHIF — Social Health Insurance Fund Linda Mama EduAfya NHIF (legacy cards)

Eligibility and benefits follow the current rules of the Social Health Authority (SHA) and applicable government programmes.

Private insurers & employer schemes

Jubilee Health AAR APA Britam CIC Madison Resolution Pioneer Minet Old Mutual GA Life Heritage + other licensed insurers

Names shown for identification only — listing does not imply partnership or guarantee of coverage.

Have these ready when we check

  • Insurer or scheme name & policy / member number
  • A clinician's request / prescription for the test
  • Pre-authorisation letter, if your plan requires one

Free coverage check

Ask us to verify your cover

Send your details and our claims team confirms what documents you need and whether pre-authorisation applies — usually the same working day.

+254

Used only to process your coverage check — see our Privacy Policy. Verification support is free and does not guarantee your provider will pay.

01

Start with fit

Is this the right test for you?

The best test starts with a clear clinical question. These are common reasons a clinician or family may consider this test.

  • ✓Suspected Toxoplasmosis based on symptoms (fever, muscle pain, swollen lymph nodes).
  • ✓Individuals with weakened immune systems (e.g., HIV/AIDS, transplant recipients, chemotherapy patients).
  • ✓Pregnant women with suspected exposure or symptoms.
  • ✓Newborns with suspected congenital Toxoplasmosis.
  • ✓Monitoring treatment response in infected individuals.
  • ✓Confirmation of exposure in specific epidemiological investigations.
02

In plain language

What this test helps you understand

This test helps confirm an active Toxoplasma gondii infection by detecting its RNA. It is particularly useful for diagnosing Toxoplasmosis in immunocompromised individuals, pregnant women, and newborns, where early detection and treatment are crucial to prevent severe complications.
The Toxoplasma Gondii RNA Detection Qualitative Test is a diagnostic tool used to identify the presence of the Toxoplasma gondii parasite. This parasite can cause Toxoplasmosis, a condition that can lead to serious health complications, especially in individuals with compromised immune systems, pregnant women, or newborns.

This test specifically looks for the RNA (genetic material) of the parasite in various samples. Detecting RNA indicates an active infection, allowing healthcare providers to initiate appropriate treatment promptly. The test utilizes advanced Real-Time PCR technology, known for its accuracy and speed in detecting infectious agents.

If you are experiencing symptoms potentially related to Toxoplasmosis, such as fever, muscle aches, swollen lymph nodes, or flu-like symptoms, or if you belong to a high-risk group, this test may be recommended by your doctor.
03

Medical review status

Clinical review pending

A completed medical review is not recorded for this page. No clinician has endorsed the information shown here. Please discuss testing decisions with a qualified healthcare professional.

Meet the DNA Labs Kenya medical team →
04

A simple process

What happens next?

You do not have to navigate the test alone. We help you move from question to next step.

1

Speak with us

We check the test and answer your questions before collection.

2

Give your sample

Choose home collection or a coordinated hub visit in Kenya. We explain whether this test uses a cheek swab or blood draw.

3

Understand your report

A counselor helps you understand the result and the next steps.

05

Choose your collection

Home collection or a lab visit

We will explain the sample, preparation, and next steps before anything is collected.

Home collection

Choose a coordinated visit at home or another convenient location. Our team confirms the appointment and sample requirements in advance.

Lab or hub visit

Prefer to visit a coordinated location? We can guide you to the right hub and explain what to expect when you arrive.

Ask about locations →
PreparationGenerally, no special preparation is required for this test. However, confirm any specific instructions with the laboratory or your doctor.
SampleWhole blood, urine, serum, tissue, or aqueous humor. Confirm specific sample type required with the laboratory before booking.
MethodologyReal-Time Polymerase Chain Reaction (PCR).
PrivacyYour sample and report are handled confidentially. Ask the team how your information is stored and shared.
This test detects the presence of Toxoplasma gondii RNA, indicating an active infection. It does not detect past infections or antibodies. False negatives can occur if the parasite load is very low or if the sample is collected improperly. False positives are rare but possible due to contamination.
06

Read your report

What common result terms mean

PositiveA finding was identified. Your clinician or counselor will explain what it means for your care.
NegativeThe specific finding tested for was not identified. It does not rule out every possible cause.
VUSA variant was found, but current evidence is not enough to classify it. Your counselor can explain follow-up.
07

Questions people ask

Frequently asked questions

Toxoplasmosis is an infection caused by the parasite Toxoplasma gondii. Many people infected have no symptoms, but it can cause serious illness in individuals with weakened immune systems, pregnant women, and newborns.
Detecting an active Toxoplasma gondii infection early allows for timely treatment, which can prevent severe complications, especially in vulnerable populations like pregnant women and immunocompromised individuals.
The test can be performed on various samples, including whole blood, urine, serum, tissue, or aqueous humor. Please confirm the required sample type with the laboratory.
The Real-Time PCR method used is highly accurate for detecting the parasite's RNA. However, like all tests, there is a small possibility of false positive or false negative results.
A positive result indicates the presence of Toxoplasma gondii RNA, suggesting an active infection. A negative result suggests no current infection was detected in the sample. Discuss your results with your healthcare provider.
Turnaround time varies. Please confirm the expected turnaround time with the laboratory before booking your test.
08

Collaboration

Open for partnership with hospitals, clinics, doctors & researchers

Whether you are referring patients, building a research programme or supporting students, we work as an extension of your team — with responsive communication and clear scientific standards.

Hospitals & clinics

Referral pathways, coordinated sample logistics and shared reporting that fits your clinical workflow.

Doctors & specialists

LOINC-coded reports, ACMG-based variant classification and a direct scientific line for complex cases.

Research institutions

Sanger sequencing, NGS panels and custom assays — with project design support, batch pricing and agreed turnaround commitments.

Students & academic projects

Discounted laboratory services for college, master's and PhD research projects — including proposal guidance and cost-effective batch testing.

Explore partnerships
09

Trust & transparency

Sources, standards & how this page is maintained

Standards & references

  • ACMG/AMP technical standards for sequence variant interpretation
  • ClinGen curation and gene–disease validity frameworks where applicable
  • LOINC-coded reporting for interoperable results
  • ISO 9001:2015 quality management; ISO 15189 accreditation in progress

Page provenance

  • Last updated: September 27, 2026
  • Medical review: not yet completed
  • Written for patients & clinicians in Kenya; reviewed periodically against current guidance

Medical disclaimer: this page is general information, not a diagnosis or personal medical advice. Testing decisions and result interpretation should be made with a qualified healthcare professional.

Keep exploring

Related tests

View all tests →
Chat on WhatsApp